CRIS Current Research Information System

AMBROSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.742
AS - Asia 8.049
EU - Europa 6.404
SA - Sud America 613
AF - Africa 478
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.649
CN - Cina 2.276
SG - Singapore 2.228
VN - Vietnam 2.113
GB - Regno Unito 1.985
DE - Germania 899
IT - Italia 837
SE - Svezia 636
HK - Hong Kong 559
BR - Brasile 448
RU - Federazione Russa 418
IN - India 406
UA - Ucraina 357
FR - Francia 270
IE - Irlanda 260
ZA - Sudafrica 139
KR - Corea 130
EE - Estonia 119
CI - Costa d'Avorio 110
FI - Finlandia 109
NL - Olanda 108
CH - Svizzera 106
JP - Giappone 103
TG - Togo 97
AR - Argentina 76
SC - Seychelles 66
AT - Austria 58
JO - Giordania 48
BG - Bulgaria 47
BE - Belgio 40
CA - Canada 40
ES - Italia 40
ID - Indonesia 39
NG - Nigeria 38
MX - Messico 34
PL - Polonia 28
TR - Turchia 28
IR - Iran 25
BD - Bangladesh 24
GR - Grecia 24
CO - Colombia 20
EC - Ecuador 20
PY - Paraguay 20
IQ - Iraq 17
HR - Croazia 14
CL - Cile 13
AU - Australia 9
CZ - Repubblica Ceca 9
LT - Lituania 9
LB - Libano 8
MA - Marocco 7
TW - Taiwan 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 5
EG - Egitto 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BJ - Benin 4
CR - Costa Rica 4
DK - Danimarca 4
IL - Israele 4
MD - Moldavia 4
MY - Malesia 4
PE - Perù 4
RO - Romania 4
TT - Trinidad e Tobago 4
AL - Albania 3
BO - Bolivia 3
NO - Norvegia 3
PA - Panama 3
PH - Filippine 3
PK - Pakistan 3
SM - San Marino 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
EU - Europa 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
MU - Mauritius 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NP - Nepal 1
Totale 25.295
Salva come PNG Salva come JPEG
Città #
Southend 1.798
Singapore 1.379
Fairfield 1.160
Ashburn 934
Chandler 735
Hong Kong 552
Woodbridge 543
Seattle 509
Houston 508
Wilmington 478
Princeton 407
Cambridge 384
Dong Ket 384
Beijing 339
Santa Clara 307
Ho Chi Minh City 306
Ann Arbor 276
Hefei 271
Dublin 260
Boardman 254
Hanoi 243
Jacksonville 217
Bologna 172
Nanjing 168
Westminster 160
Padova 144
Los Angeles 130
Seoul 128
Berlin 111
Abidjan 110
Lomé 97
Bern 96
Jinan 92
Dallas 91
New York 91
Buffalo 89
Shenyang 88
Helsinki 86
Tokyo 84
Saint Petersburg 76
Milan 72
Hebei 66
Redondo Beach 65
Redmond 62
Changsha 59
Guangzhou 59
Medford 56
São Paulo 56
Tianjin 53
Mülheim 51
San Diego 50
Nanchang 49
Amman 48
Turin 48
Shanghai 47
Bremen 44
Munich 40
Sofia 40
Zhengzhou 40
Chicago 39
Abeokuta 35
Vienna 34
Dearborn 33
Frankfurt am Main 32
Haiphong 32
Jiaxing 32
Brussels 31
Redwood City 30
Yubileyny 30
Bengaluru 29
Da Nang 29
Des Moines 28
Hangzhou 28
Nuremberg 28
Falkenstein 26
Florence 26
Falls Church 24
Haikou 24
Phoenix 24
Mahé 23
London 22
Tongling 21
Columbus 20
Kuban 20
Olalla 20
Rome 20
Taiyuan 20
Kunming 19
Norwalk 19
Thái Nguyên 19
Biên Hòa 18
Taizhou 18
Wuhan 18
Jakarta 17
Lappeenranta 17
Can Tho 16
Rio de Janeiro 16
Vũng Tàu 16
Bắc Ninh 15
Ningbo 15
Totale 16.245
Salva come PNG Salva come JPEG
Nome #
Merkel cell carcinoma: a prompt diagnosis to increase survival 623
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 311
68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessment: Results of a prospective study on 50 patients 254
F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease 243
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 241
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 234
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 216
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 208
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 200
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy 198
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 197
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 196
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 196
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients. 195
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 192
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 188
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 185
11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. 184
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. 183
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 182
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 181
18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study 180
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease. 176
18F-FDG PET/CT detects systemic involvement in Sarcoidosis 176
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 171
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 170
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 168
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 166
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET. 166
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. 164
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. 164
18f-fdg pet/ct for restaging gastric cancer after surgical resection 164
Discordant response to chemotherapy: An unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients 161
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results 161
68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. 160
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results 158
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 158
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL 156
Colon Sarcoidosis Mimicking Cancer at 18F-FDG PET/CT 154
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 152
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 151
Preliminary evaluation of 68Ga-DOTA-NOC PET/CT in patients with idiopathic pulmonary fibrosis 150
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 149
Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma 148
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 148
68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. 148
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 148
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 146
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 145
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 144
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 144
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 144
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma 143
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms 143
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 142
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. 142
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 142
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. 141
Analisi in vitro ed in vivo dell'attività anti-tumorale dopo inibizione specifica di MYCN mediante PNA-NLS anti-gene nel rabdomiosarcoma umano 141
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 141
Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. 138
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update 137
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? 137
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. 137
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 137
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 136
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 135
A new dimension of FDG-PET interpretation: assessment of tumor biology. 135
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 134
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 134
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 134
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms 133
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models. 132
Preliminary results of the Italian FOLCETUX study: early evaluation of treatment response with 18FDG PET in gastric or gastroesophageal junction adenocarcinoma. 130
Small animal PET for the evaluation of an animal model of genital infection 130
Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 128
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma 128
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 128
Is there an ideal diagnostic algorithm in solitary pulmonary nodules? 127
TÉCNICAS DE MEDICINA NUCLEAR EN LA VALORACIÓN DE LOS TUMORES NEUROENDOCRINOS 126
Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature 126
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 126
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 126
FDG small animal PET permits early detection of malignant cells in a xenograft murine model. 126
FDG-PET in the serial assessment of patinets with lymphoma in complete remission 125
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. 125
18F-FDG PET/CT impact on testicular tumours clinical management 125
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 124
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma. 124
Performance evaluation of a small animal PET scanner. Spatial resolution characterization using F-18 and C-11. 123
Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF 122
68Ga-DOTA-NOC PET and CT retrospective analysis for neuroendocrine bone metastasis detection 121
Pitfalls in oncology: Osteoblastic response mimicking bone progression during ceritinib treatment in ALK-rearranged NSCLC 121
Molecular Imaging with Small Animal PET/CT 119
Usefulness of FDG-PET in detection of local and distant recurrent cervical cancer in symptomatic women 118
Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients 118
Lung cancer associated with cystic airspaces 118
Small animal PET in oncology: the road from bench to bedside. 118
Neuroendocrine Tumours Pictorial Atlas 118
[68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results 118
Totale 15.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.762 0 0 0 0 0 86 44 249 297 137 170 779
2021/20223.781 846 112 204 222 298 178 55 252 140 138 818 518
2022/20233.481 385 509 207 435 211 245 100 183 563 189 265 189
2023/2024885 96 159 40 77 72 167 53 56 34 61 35 35
2024/20254.052 144 648 350 254 626 210 512 94 48 191 199 776
2025/20265.070 755 1.313 874 722 1.086 320 0 0 0 0 0 0
Totale 25.727